Navigation Links
EnzySurge, Maker of DermaStream(TM), Completes Funding Round of US$4 Million
Date:6/2/2008

Proceeds Will be Used to Accelerate Market Entry of its Wound Care Products

RICHMOND, Virginia and ROSH HA'AYIN, Israel, June 2 /PRNewswire/ -- EnzySurge Ltd. (EnzySurge), a provider of innovative solutions for advanced chronic wound management, announced today that it successfully completed its latest round of funding of US $4 million. The round was extended from $2 million, as was announced on January 2008, to $4 million and was led by Eli Gilboa from Gilboa&Licht, who is the company's chairman. To date, the company has raised a total US$7.3 million. With this additional capital, the company will be positioned to execute on its plan to commercialize its products, for market launch in early 2009. The addressable market for DermaStream(TM) advanced wound care products is estimated by industry analysts to be US$6 billion.

EnzySurge's DermaStream(TM) product line is based on its proprietary Continuous Streaming Therapy (CST(TM)) technology. The comprehensive system continuously streams a fresh supply of active solutions to a controlled wound environment. EnzySurge has developed a series of bio-active therapeutic solutions to facilitate safe and effective healing of chronic wounds through all phases, from debridement, through regeneration to closure. The DermaStream family of products is designed to treat all forms of chronic wounds including diabetic ulcers, venous ulcers and pressure ulcers. DermaStream touch-free treatments result in faster, more effective and painless wound healing in the hospital, clinics and at home.

EnzySurge is currently completing the 2nd phase of a multi-centered, double blind clinical trial focused on chronic leg ulcers (venous ulcers). The intermediate results of the trial indicate a significant improvement and acceleration in treatment.

"I am very excited about the results of our most recent clinical trials and the feedback we are receiving since initiating our marketing activities in the US," says Amir Shine
'/>"/>

SOURCE EnzySurge Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. EnzySurge, Maker of DermaStream(TM), Establishes a US Office in the Virginia Biotech Commercialization Center
2. Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers
3. Ortho Evra Patch Makers Settling Cases
4. New research shows that iPods do not interfere with cardiac pacemakers
5. Bioscience Group Warns Policymakers Against Complacency
6. BSP Pharma Inc., Makers of FlexNow(TM) Joint Formula Sign Distribution Deal with Vitamin Shoppe and GNC
7. Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Healthcare Conference
8. BioCryst to Present at the BioCentury NewsMakers in the Biotech Industry Conference
9. Anesiva to Present at BioCenturys NewsMakers in the Biotech Industry Conference on September 6, 2007
10. BioMarin to Present at the BioCentury NewsMakers Conference
11. Neurocrine Biosciences to Present at the BioCentury: Newsmakers in the Biotech Industry Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ewswire-Asia/ -- The pharma and biotech sectors ar...anies are facing significant,pressure to change wi... calls for,lower prices and a greater regulatory b...l crisis have made the work of creating new drugs ... being forced to globalize their R&D,operation...
(Date:11/9/2009)...RNewswire/ -- Following the provision of clinical,...stration (FDA), privately,owned UK company Daval I...al.com ) has been informed that its innovative,ant...n Orphan-Drug,designation for the treatment of Amy...also known as Lou Gehrig,s disease, is the most co...
(Date:11/6/2009)...RNewswire-FirstCall/ -- BioSpecifics Technologies ...y developing first-in-class collagenase-based prod...e third quarter ended September 30, 2009. ,, "... year, the FDA,s Arthritis Advisory Committee unan...al of XIAFLEX(TM) for the treatment of Dupuytren,s...
(Date:11/6/2009)...v. 6 Calbiotech, Inc. announced to...vative Research (SBIR) Phase I contract by the U.S...r terms of the agreement, Calbiotech will develop ... of Dengue virus. ,, Dengue virus is a mosqu... to military forces deployed to tropical areas of ...
Breaking Biology Technology:Pharma and Biotech Leaders to Converge in Shanghai 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2
...b3c newswire /  - Rentschler Biotechnologie a... biopharmaceutical development and production, hav...operation will enable Rentschler Biotechnologie&rs...im’s large-scale mammalian biopharmaceutical...ce versa, Boehringer Ingelheim’s clients to ...
...rapeutics (Prime), a,thought leader in pharmacy be...ived accreditation from the National Association o...fied Internet Pharmacy Practice,Sites(TM) (VIPPS(R...tablished by NABP in response to,consumers, concer...he,Internet. VIPPS accreditation further authentic...
...stems, Inc., a,privately held company that manufac...nnounced today the newest installation of the PEM ... P.C. in Rockville Centre, New York.,This installa...een Naviscan,and the operators of Rockville PET Im...ging technology to multiple centers throughout the...
Other Biology Technology:Rentschler Biotechnologie Announces Cooperation with Boehringer Ingelheim 2Rentschler Biotechnologie Announces Cooperation with Boehringer Ingelheim 3Prime Therapeutics Receives VIPPS Accreditation 2Naviscan PET Systems and Rockville PET Imaging Partner to Bring a New Breast Imaging Technology to New York 2Naviscan PET Systems and Rockville PET Imaging Partner to Bring a New Breast Imaging Technology to New York 3
(Date:11/9/2009)...the Netherlands, November 09, 2009 / b3c newswire...ization, and Seventh Wave, an American organizatio...that the companies have signed a letter of intent ...tinal models TIM. The letter of intent proposes a ...o TIM systems for commercialization in North Ameri...
(Date:11/9/2009)...ELPHIA Scientists and industry leaders from aroun..., for the AACR-NCI-EORTC Molecular Targets and Can...ill feature groundbreaking information on importan... a complex disease and to treat it effectively we ...takes place at the molecular level," said Lewis Ca...
(Date:11/8/2009)...T LAFAYETTE, Ind. - Researchers at Purdue Universi...maged nerve fibers in spinal cord injuries using n...shortly after an accident. , The synthetic "copo... nanometers in diameter, or roughly 100 times smal...earchers have been studying how to deliver drugs f...
Breaking Biology News(10 mins):TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services 2Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Depression May Lead to More Preemies Among Blacks 49006 1Depression May Lead to More Preemies Among Blacks 49006 2Good news for some hard to treat hepatitis C patients 49004 1Good news for some hard to treat hepatitis C patients 49004 2Nuvo Research and Covidien sign U S license and development agreement for Pennsaid 28R 29 and Pennsaid Plus 28R 29 49003 1Nuvo Research and Covidien sign U S license and development agreement for Pennsaid 28R 29 and Pennsaid Plus 28R 29 49003 2Nuvo Research and Covidien sign U S license and development agreement for Pennsaid 28R 29 and Pennsaid Plus 28R 29 49003 3
...mmals React to Underwater Sound , Connie Barclay,...ries Service is looking at how marine mammals reac...ts that exposure to intense underwater sound in so...rand and ultimately die. Some of these strandings ...itary sonar, and most have involved beaked whales;...
... newly sequenced genome of a one-celled, planktoni...14) in the journal Nature, is already telling scie...nied the jump from one-celled life forms to multic...aper and a complementary Science paper also releas...biologists Nicole King, Daniel Rokhsar and their c...
...vast and far-reaching as the worlds oceans are, ev...es, according to a study in the journal Science by...t Chapel Hill and others. , The international tea...ects of global change from overfishing to global ...ems, such as coral reefs and continental shelves. ...
Other Biology News:NOAA science story tips -- AAAS 2008 edition 2NOAA science story tips -- AAAS 2008 edition 3NOAA science story tips -- AAAS 2008 edition 4NOAA science story tips -- AAAS 2008 edition 5NOAA science story tips -- AAAS 2008 edition 6NOAA science story tips -- AAAS 2008 edition 7Genome of marine organism tells of humans' unicellular ancestors 2Genome of marine organism tells of humans' unicellular ancestors 3Genome of marine organism tells of humans' unicellular ancestors 4First map of threats to marine ecosystems shows all the world's oceans are affected 2
Ribonucleic acid, transfer from baker's yeast (S. cerevisiae) from Sigma-Aldrich
Ribonucleic acid, transfer from baker's yeast (S. cerevisiae) from Sigma-Aldrich
...ct measuring instrument for calibrating single-cha...ompact design and the robust carrying case, the MC... laboratory and on-site at the users premises. The...ual channels are tested automatically. Multi-chann...
...tol DTT White solid.. PACKAGED UNDER INERT GAS. ...action is "driven" to completion. A protective age... found in many other preparations. Blocks the leth... ≥97% by titration. Contaminants: Heavy metal...
Biology Products: